Diplomat Pharmacy

$5.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (1.22%) As of 12:00 AM EDT pre-market
+$0.07 (1.22%) Pre-Market

Why Robinhood?

You can buy or sell DPLO and other stocks, options, ETFs, and crypto commission-free!

About DPLO

Diplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates through the Specialty and Pharmacy Benefit Management segments. Read More The Specialty segment offers a range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost specialty drugs, and a wide range of applications. The Pharmacy Benefit Management segment provides services designed to help the customers reduce the cost and manage the complexity of their prescription drug programs. The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI.

Employees
2,335
Headquarters
Flint, Michigan
Founded
1975
Market Cap
440.57M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.07M
High Today
$5.82
Low Today
$5.68
Open Price
$5.77
Volume
508.53K
52 Week High
$21.48
52 Week Low
$4.17

Collections

DPLO News

ReutersAug 15

Edited Transcript of DPLO earnings conference call or presentation 9-Aug-19 12:30pm GMT

6
BenzingaAug 9

Diplomat Pharmacy - Diplomat Pharmacy Reports Q2 Earnings Beat, Will Explore Strategic Alternatives

204

DPLO Earnings

-$0.25
-$0.09
$0.07
$0.23
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.13 per share
Actual
-$0.25 per share

More DPLO News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.